Open AccessPROSPECTIVE OBSERVATIONAL STUDY ON MYOCARDIAL INFARCTION IN RELATIONSHIP WITH VARIOUS RISK FACTORS
Author(s) -
Kames Waran,
Linu P Baby,
Neema Johnson,
Shyamily John,
R Sambathkumar
Publication year - 2016
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2016.v9s3.13735
Subject(s) - medicine , myocardial infarction , observational study , prospective cohort study , obesity , smoking cessation , risk factor , physical therapy , cardiology , pathology
Objective: The aim of this study was to determine the prevalence of risk factors which influence the increased rate of myocardial infarction in atertiary care hospital.Methods: Data for this 6 months prospective observational study were collected from 227 patients admitted to a tertiary care hospital with acutemyocardial infarction, through patient interviews and case reports and were analyzed.Results: A total of 227 cases were taken for this study. Out of 227 patients, 168 (74.19%) were males and 59 (25.81%) were females. This studyreveals some major risk factors which contribute the increased rate of myocardial infarction and were smoking, chronic alcoholism, obesity, sedentarylifestyle, male sex, physical inactivity, comorbid diseases, sleep disorders as well as age group between 41 and 60 years. No association between oilconsumption coffee intake and a positive association between tea intake was observed. Out of 105 patients diagnosed with ST elevated MI, 55 (52.23%)were treated with fibrinolytic therapy and 50 (47.77%) were excluded from this therapy mainly due to delayed admission. All the patients were foundto be benefited by beta-blocker therapy.Conclusion: Results suggested that awareness regarding moderate physical activity, cessation of cigarette smoking, increased daily consumption offruits and vegetables may reduce the increased myocardial infarction risk.Keywords: Myocardial infarction, Risk factors, Fibrinolytic therapy, Beta blockers.